DI
CYTK icon

Disciplined Investments’s Cytokinetics CYTK Stock Holding History

Disciplined Investments’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3
Closed -$98 – 454
2023
Q2 		$98 Hold
3
– – ﹤0.01% 1599
2023
Q1 		$106 Buy
+3
New +$122 ﹤0.01% 1568

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Disciplined Investments's CYTK Position: Q3 2023 in Review

Disciplined Investments sold out of Cytokinetics (CYTK) in Q3 2023, closing a stake of 3 shares — an estimated $98 sold.

Disciplined Investments first reported a position in CYTK in Q1 2023 and held it in 2 quarters. The position peaked at $106 in Q1 2023. 250 funds tracked by Wall St. Rank hold CYTK as of Q3 2023.

  • Disciplined Investments reported no remaining Cytokinetics position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 3 Cytokinetics shares in Q3 2023, an estimated $98.
  • Disciplined Investments first reported a position in Cytokinetics in Q1 2023 and held it in 2 quarters.
  • Disciplined Investments's Cytokinetics position peaked at $106 in Q1 2023.
  • 250 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.